Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Evaluating Setmelanotide in POMC and LEPR Deficiency Obesities August 7, 2019 - NASDAQ Companies 0 » View More News for August 07, 2019